C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2006
11/09/2006	US20060253938 Nucleotide sequences and method of using same to increase plant stress tolerance
11/09/2006	US20060253937 Transgenic plants has DNA in its genome; nucleotide sequence encoding an enzyme to catalyze the biosynthesis of peroxisomes, biodegradable polylactone thermoplastics; transgenic crops, fruits, seeds
11/09/2006	US20060253936 Novel constructs and their use in metabolic pathway engineering
11/09/2006	US20060253935 Expression of human serum albumin insulin in plastids
11/09/2006	US20060253934 Methods for conditional transgene expression and trait removal in plants
11/09/2006	US20060253930 Cyclin-dependent kinase inhibitors as plant growth regulators
11/09/2006	US20060253929 Plants with reduced activity of a class 3 branching enzyme
11/09/2006	US20060253928 Optimizing glycan processing in plants
11/09/2006	US20060253927 Method for the production of zeaxanthin and/or biosynthetic intermediates and/or subsequent products thereof
11/09/2006	US20060253926 Enoyl-ACP reductases
11/09/2006	US20060253925 Coleopteran-toxic polypeptide compositions
11/09/2006	US20060253924 Nucleotide sequences involved in disease resistance
11/09/2006	US20060253923 DNA shuffling to produce herbicide selective crops
11/09/2006	US20060253922 DNA shuffling to produce herbicide selective crops
11/09/2006	US20060253921 Identification of a new class of EPSP synthases
11/09/2006	US20060253920 Nucleic acid sequence encoding a plant phytase conferring the ability to hydrolyze phytate; plant genes involved in phosphorous uptake; exhibiting improved phosphorous utilization
11/09/2006	US20060253919 Nucleic acid molecules and other molecules associated with soybean cyst nematode resistance
11/09/2006	US20060253917 Cell proliferation-related polypeptides and uses therefor
11/09/2006	US20060253916 transgenic plants with genetically modified plastids; at least one enzyme is expressed in the plastid of a plant or plant cell or expressed in the nucleus and transported to the plastid of a plant or plant cell
11/09/2006	US20060253913 Production of hSA-linked butyrylcholinesterases in transgenic mammals
11/09/2006	US20060253912 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
11/09/2006	US20060253192 Production of tissue engineered heart valves
11/09/2006	US20060252981 Biocompatible implant and use of the same
11/09/2006	US20060252922 Compositions, splice variants and methods relating to colon specific genes and proteins
11/09/2006	US20060252690 Factor VII or VIIa - Like Molecules
11/09/2006	US20060252689 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/09/2006	US20060252157 Larynx carcinoma-associated protein larcap-1
11/09/2006	US20060252153 Retroviral vectors for delivery of interfering rna
11/09/2006	US20060252152 Attachment of cells to surfaces
11/09/2006	US20060252151 Stem cell and dental pulp harvesting method and apparatus
11/09/2006	US20060252150 Human embryonic stem cell cultures, and compositions and methods for growing same
11/09/2006	US20060252149 Cns cells in vitro
11/09/2006	US20060252148 Container for germ layer formation and method of forming germ layer
11/09/2006	US20060252147 Method of identifying target cell using target cell-specific virus
11/09/2006	US20060252132 Influenza hemagglutinin and neuraminidase variants
11/09/2006	US20060252131 Deoxynucleoside kinase from insect cells for the synthesis of nucleoside monophosphates
11/09/2006	US20060252130 Method for linking molecular substances
11/09/2006	US20060252127 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/09/2006	US20060252125 ICE/CED-3 like protease designated FMH-1
11/09/2006	US20060252124 Methods and compositions for generating human monoclonal antibodies
11/09/2006	US20060252120 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
11/09/2006	US20060252110 Assays for the detection of biliverdin in birds and reptiles
11/09/2006	US20060252107 Compositions and methods for diagnosing and treating retinal diseases
11/09/2006	US20060252105 Monoclonal antibody and hybridoma producing the same
11/09/2006	US20060252104 Screening for a compound to inhibit the urge for urinary incontinence by detecting activation of KCNQ protein in the host cell; measuring the membrane potential of the host cell and selecting the compound whose presence causes hyperpolarization in themembrane potential of the host cell
11/09/2006	US20060252062 System and process for genetic and epigenetic treatment
11/09/2006	US20060252048 Method for testing ghrelin release
11/09/2006	US20060252046 Plasma polymerisation methods for the deposition of chemical gradients and surfaces displaying gradient of immobilised biomolecules
11/09/2006	US20060252037 Expression vector comprising antisense nuclelotide sequence which decrease exxpression from kinase suppressor of RAS (KRAS) for use in the treatment and prevention of cell proliferative disorders
11/09/2006	US20060252036 Alteration of rab38 function to modulate mammalian pigmentation
11/09/2006	US20060252034 Novel protein containing ring finger domaine r1p4
11/09/2006	US20060252026 Cryopreservation method for bivalve oocytes
11/09/2006	US20060251735 Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
11/09/2006	US20060251683 Directly injectable formulations which provide enhanced cryoprotection of cell products
11/09/2006	US20060251682 soluble and stable in physiological media; have an additional Cys residue compared with the wild type; utilised for the therapy of grass pollen-induced allergies
11/09/2006	US20060251671 Haemophilus influenza outer membrane protein and use thereof in vaccination
11/09/2006	US20060251666 Cancer antigens and utilization thereof
11/09/2006	US20060251665 Vaccines
11/09/2006	US20060251658 Antibodies to TGF-beta
11/09/2006	US20060251655 Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same
11/09/2006	US20060251648 Nucleotide sequences coding transport protein for use in identifying modulators for treatment of pain; flavor enhancement
11/09/2006	US20060251646 Anti-tirc7 antibodies in therapy of inflammatiory diseases
11/09/2006	US20060251645 Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith
11/09/2006	US20060251644 or an antigen binding fragment comprising variable light chain region and heavy chain peptides, directed against isotypic determinants of immunoglobulin E (IgE), useful for diagnostics, prophylaxis and treatment of disease such as asthma, rhinitis, eczema, urticaria. dermatitis or food allergies
11/09/2006	US20060251642 Modulation of stem cells using zinc finger proteins
11/09/2006	US20060251635 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
11/09/2006	US20060251631 Treatment of joint disease, methods and apparatuses therefor
11/09/2006	US20060251630 Encapsulated cell therapy
11/09/2006	US20060251628 Defatted, dewatered bone marrow
11/09/2006	US20060251624 Cells exhibiting neuronal cell progenitor characteristics and methods of making them
11/09/2006	US20060251622 Container for serum production and method of regenerative medicine using the same
11/09/2006	US20060248795 Method of manufacturing a growth substrate
11/09/2006	DE102005021509A1 Tissue culture allowing production of spaced vessels, vessel dressings or hollow organs involves colonization of a biodegradable or permanent carrier
11/09/2006	DE102005021435A1 Verfahren zur serum-/proteinfreien Kultur von Stamm- und Progenitorzellen Method for serum- / protein-free culture of stem and progenitor cells
11/09/2006	CA2836827A1 Alpha amino acid ester-drug conjugates hydrolysable by carboxylesterases
11/09/2006	CA2607586A1 Synthetic and standardized prion infectuous material, and uses thereof as an infecting inoculum
11/09/2006	CA2607160A1 Transgenic expression cartridges for expressing nucleic acids in the flower tissue of plants
11/09/2006	CA2607060A1 Selecting, culturing and creating lineage committed hematopoietic stem cells
11/09/2006	CA2607016A1 Improved somatic embryogenesis and embryo harvesting and method and apparatus for preparing plant embryos for plant production
11/09/2006	CA2606983A1 Method of preparing organ for transplantation
11/09/2006	CA2606489A1 Method for identification of compound having antidepressant effect
11/09/2006	CA2606450A1 Anti-platelet membrane glycoprotein vi monoclonal antibody
11/09/2006	CA2606177A1 Novel polypeptide and use thereof
11/09/2006	CA2604608A1 Antibody directed against gastrin-releasing peptide precursor and use thereof
11/08/2006	EP1719779A2 Antibodies against Matin
11/08/2006	EP1718751A2 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
11/08/2006	EP1718749A1 Humanized antibody
11/08/2006	EP1718737A1 Cancerous disease modifying antibodies
11/08/2006	EP1718736A1 Cancerous disease modifying antibodies
11/08/2006	EP1718735A1 Stem cell populations and methods of use
11/08/2006	EP1718734A1 Methods for genetic diversification in gene conversion active cells
11/08/2006	EP1718733A2 Compositions and methods relating to culturing neural stem cells with bone marrow stromal cells
11/08/2006	EP1718732A1 Methods of making and using skin-derived stem cells
11/08/2006	EP1718729A2 Culture media compositions free of fetal bovine serum
11/08/2006	EP1718726A2 Cell/tissue culturing device, system and method
11/08/2006	EP1718677A2 Monovalent antibody fragments useful as therapeutics
11/08/2006	EP1718664A2 Modified human four helical bundle polypeptides and their uses
11/08/2006	EP1718659A1 Vectors having both isoforms of beta-hexosaminidase and uses of the same
11/08/2006	EP1718339A2 Modified human interferon polypeptides and their uses
11/08/2006	EP1636360A4 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site

1 ... 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 ... 1827